Wanming Shi

Title: Wanming Shi: Innovator in Transaminase Mutants

Introduction

Wanming Shi is a notable inventor based in Tianjin, China. He has made significant contributions to the field of biochemistry, particularly in the development of transaminase mutants. His work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Wanming Shi holds a patent for a transaminase mutant and its use. The patent describes an amino acid sequence of the transaminase mutant, which is derived from a mutation of a specific amino acid sequence shown in SEQ ID NO: 1. The mutations occur at various sites, including G17V, L36P, Q40H, G69Y, H70T, L73A, V77G, V77S, V77T, A78I, Y130M, Y130V, Y130T, N132I, N132T, K141S, K142S, K142T, R143P, G144F, G144W, G144Y, E145D, E145S, E145G, K146R, L148A, and L148I, among others. This innovation has the potential to enhance the efficiency of biochemical processes.

Career Highlights

Wanming Shi is currently employed at Asymchem Laboratories (Fuxin) Co., Ltd. His role at the company allows him to further his research and development efforts in the field of biochemistry. His expertise and innovative approach have positioned him as a valuable asset in his industry.

Collaborations

Some of Wanming Shi's coworkers include Hao Hong and Gage James. Their collaborative efforts contribute to the advancement of research and development projects within their organization.

Conclusion

Wanming Shi is a distinguished inventor whose work on transaminase mutants showcases his commitment to innovation in biochemistry. His contributions are paving the way for advancements in biotechnology and pharmaceuticals.